University of Helsinki, Clinicum, and Helsinki University Hospital, Helsinki, Finland.
University of Helsinki, Clinicum, and Helsinki University Hospital, Helsinki, Finland.
Clin Nutr. 2020 May;39(5):1491-1496. doi: 10.1016/j.clnu.2019.06.011. Epub 2019 Jun 21.
BACKGROUND & AIMS: Prognostic significance of metabolically healthy overweight and obesity (MHO) is under debate. However the relationship between MHO and health-related quality of life (HRQoL) is less studied. We compared successful aging (longevity plus HRQoL) in men with MHO, metabolically healthy normal weight (MHN) and metabolically unhealthy overweight and obesity (MUO).
In the Helsinki Businessmen Study longitudinal cohort, consisting of men born 1919 to 1934. In 1985/86, overweight (BMI≥25 kg/m) and metabolic health were determined in 1309 men (median age 60 years). HRQoL was assessed using RAND-36/SF-36 in 2000 and 2007, and all-cause mortality retrieved from registers up to 2018. The proportion of men reaching 90 years was also calculated.
Of the men, 469 (35.8%), 538 (41.1%), 276 (21.1%), and 26 (2.0%) were MHN, MHO, MUO and MUN, respectively. During the 32-year follow-up, 72.3% men died. With MHN as reference, adjusted hazard ratio with all-cause mortality was 1.08 (95% confidence interval [CI] 0.93 to 1.27) for MHO, and 1.18 (95% CI 0.95 to 1.47) for MUO. During follow-up, 273 men reached 90 years. With MHN as reference, adjusted odds ratio for MHO was 0.82 (95% CI 0.59 to 1.14) and 0.62 (95% CI 0.41 to 0.95) for MUO. Men in MHN group scored generally highest in RAND-36 HRQoL subscales in 2000 and 2007, of those significantly better in Physical functioning, Role physical, Role emotional, Bodily Pain, and General health sub-scales compared to MHO group in 2000.
As compared to MHN, MHO in late midlife does not increase mortality, but impairs odds for successful aging.
代谢健康型超重和肥胖(MHO)的预后意义仍存在争议。然而,MHO 与健康相关生活质量(HRQoL)之间的关系研究较少。我们比较了代谢健康型超重和肥胖(MUO)与代谢健康型正常体重(MHN)和代谢不健康型超重和肥胖(MUN)男性的成功老龄化(长寿加 HRQoL)。
在赫尔辛基商人研究的纵向队列中,包括 1919 年至 1934 年出生的男性。1985/86 年,对 1309 名男性(中位年龄 60 岁)进行超重(BMI≥25kg/m)和代谢健康的测定。2000 年和 2007 年使用 RAND-36/SF-36 评估 HRQoL,2018 年从登记处检索全因死亡率。还计算了达到 90 岁的男性比例。
男性中,分别有 469 名(35.8%)、538 名(41.1%)、276 名(21.1%)和 26 名(2.0%)为 MHN、MHO、MUO 和 MUN。在 32 年的随访中,72.3%的男性死亡。以 MHN 为参照,全因死亡率的调整后危险比(HR)为 1.08(95%置信区间 [CI] 0.93 至 1.27)为 MHO,1.18(95% CI 0.95 至 1.47)为 MUO。随访期间,273 名男性达到 90 岁。以 MHN 为参照,MHO 的调整后比值比(OR)为 0.82(95% CI 0.59 至 1.14),MUO 的调整后 OR 为 0.62(95% CI 0.41 至 0.95)。在 2000 年和 2007 年,MHN 组的 RAND-36 HRQoL 子量表的评分普遍最高,与 MHO 组相比,在身体功能、角色身体、角色情感、身体疼痛和一般健康子量表上的评分显著更好。
与 MHN 相比,中年后期的 MHO 不会增加死亡率,但会降低成功老龄化的几率。